I-2-Methyl-3-Nitrophenylacetic Acid CAS 23876-15-5 Ucoceko >99.5% (HPLC) Ropinirole Hydrochloride Intermediate

Inkcazelo emfutshane:

Igama leKhemikhali: 2-Methyl-3-Nitrophenylacetic Acid

CAS: 23876-15-5

Ubunyulu: >99.5% (HPLC)

Imbonakalo: Umgubo oMhlophe oMhlophe okanye oMthubi oMthubi

Phakathi kweRopinirole Hydrochloride (CAS: 91374-20-8)

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi ngoMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMichiza: 2-Methyl-3-Nitrophenylacetic Acid CAS: 23876-15-5

Iipropati zeMichiza:

Igama leMchiza I-2-Methyl-3-Nitrophenylacetic Acid
Izithethantonye I-2-Methyl-3-Nitro-Benzeneacetic Acid;I-Ropinirole ePhakathi 1;(3-Nitro-o-tolyl)iAcetic Acid;I-2-(2-methyl-3-nitrophenyl) i-acetic acid
Inombolo yeCAS 23876-15-5
Inombolo yeCAT RF-PI1196
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C9H9NO4
Ubunzima beMolekyuli 195.17
Indawo yokunyibilika 131.0 ~ 136.0℃
Ukunyibilika Inyibilika kwiMethanol
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo oMhlophe-obuMthubi oMthubi
Ubunyulu / Indlela yokuHlalutya >99.5% (HPLC)
Indawo yokunyibilika 130.0 ~ 137.0℃
Ilahleko ekomisweni <0.50%
Ukungacoceki Okukodwa ≤0.20%
Ukungcola ngokupheleleyo <0.50%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Phakathi kweRopinirole Hydrochloride (CAS: 91374-20-8)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-2-Methyl-3-Nitrophenylacetic Acid (i-CAS: 23876-15-5) iphakathi kwe-Ropinirole Hydrochloride (CAS: 91374-20-8).I-Ropinirole Hydrochloride yasungulwa e-UK njenge-monotherapy okanye idibene ne-levodopa yedosi ephantsi yonyango lwe-idiopathic Parkinson's disease.I-Ropinirole Hydrochloride ikwasetyenziselwa unyango lwe-moderate ukuya kwi-Restless Legs Syndrome (RLS).I-FDA yamkele ichiza lokuqala elenziwe lafana nelo lokuqala le-Ropinirole Hydrochloride, eliphuhliswe yi-GlaxoSmithKline(GSK).I-arhente ye-antiparkinsonian.I-dopamine ekhethiweyo ye-D2-receptor agonist.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi